Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
With this Collection, a partnership between Nature, Nature Medicine and Nature Communications, we welcome submissions of primary research papers that focus on neo-adjuvant immunotherapies and related combinatorial approaches (such as radio-immunotherapy or chemo-immunotherapy).
The 2023 Nobel prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.
Image: Springer Nature/The Nobel Foundation/Imagesource
The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.
Stem cell models of development, regeneration, and disease are quickly advancing. New technologies and concepts are continuously combined with existing knowledge to create more realistic systems to improve our understanding of these intricate processes.
In this collection, we highlight papers published in 2022-2023 across Nature Portfolio journals on topics including embryonic development and stem cells, reproductive biology, synthetic tissues and embryo models, clinical and translational research and tissue stem cells.
Image: Jean-Baptiste Sibarita, Virgile Viasnoff, and Anne Beghin
Anthropogenic climate change is a scientific fact. Without immediate action, we are unlikely to meet the target goal of minimizing global warming to 1.5° C. This collection highlights the importance of human behaviour in climate action, mitigation and adaptation.
Following the recent declaration from the World Health Organization that the ongoing monkeypox (now named mpox) outbreak is a Public Health Emergency of International Concern, the editorial teams at Nature Portfolio have curated a collection of relevant articles.
The Burden of Proof Studies from the Institute of Health Metrics and Evaluation provide a new method for assessing the cumulative strength of available evidence for risk factors and associated health outcomes.